Who we are

Biohope is an Argentine pharmaceutical company specialized in enabling global laboratories to establish a strategic presence in Argentina with a strong focus on rare and low-prevalence diseases. We partner with international companies to co-design market-entry strategies that align with their product, goals, and timeline. Our strength lies in combining deep local knowledge with global standards of execution.

What we stand for

We believe that innovation only creates value when it becomes accessible. Our work is grounded in ethics, efficiency, and a strong commitment to building long-term impact in the healthcare ecosystem. Biohope acts as a bridge, connecting global therapies with local presence, through a flexible and collaborative model.

We support your expansion, every step of the way

From strategy to execution, we provide the expertise, agility, and local insight global companies need to bring their therapies into Argentina, with precision and confidence.

We specialize

We focus on rare and low-prevalence diseases. Our experience allows us to navigate access pathways with clarity and strategic alignment.
01

We are agile

We adapt quickly to evolving regulatory, institutional and partner needs. Our flexible, tailor-made model ensures we make the right moves.
02

We collaborate

We work hand in hand with global partners, regulators, and institutions to co-create the most effective market-entry approach for each therapy.
03

We operate

We execute with strong local intelligence, operational excellence and compliance. We are your reliable team on the ground in Argentina.
04

Our mission

To simplify and empower the market entry of global pharmaceutical companies into Argentina, with a focus on rare and low-prevalence diseases.

Our vision

To be the strategic bridge between global innovation and local healthcare needs, with ethics, compliance, and long-term impact at the core.

A fully adaptable model for strategic market entry

At Biohope, we offer flexible operational models tailored to the needs of each licensor, from traditional distribution to modular, service-specific solutions.

Traditional Distribution Model

Includes full-service market entry:

  • Importation
  • MAA (Marketing Authorization Application)
  • Distribution and commercialization
  • Marketing and QC testing
  • Traceability and compliance

Tailor-Made Model

Build only what your business needs:

  • Modular service integration based on partner needs
  • Collaboration with local representation offices
  • Pharmacovigilance management (especially for orphan drugs)
  • QC and regulatory support (MAA)
  • Hosting and onboarding of local teams
  • Optional services available upon request

Every solution is designed to align with your product, your strategy, and your timing.